Novo Holdings Acquires BBI Group In Deal Worth Over $400M
To bolster its life sciences and diagnostics portfolios, Novo Holdings has made another major investment to acquire BBI Group.
You may also be interested in...
UK-based Venture Life has gained a foothold in the growing women's health category with the acquisition of BBI Healthcare and its leading OTC BV treatment Balance Activ.
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Babson recently raised $31m to accelerate commercialization of its blood testing “ecosystem,” developed with help from Siemens Healthineers and Becton Dickinson.